Business Description
Avid Bioservices Inc
NAICS : 325412
SIC : 2834
Description
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.63 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 1.02 | |||||
| Debt-to-EBITDA | 11.43 | |||||
| Interest Coverage | 5.01 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.83 | |||||
| Beneish M-Score | 11.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21 | |||||
| 3-Year FCF Growth Rate | -41.7 | |||||
| 3-Year Book Growth Rate | 44 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 22.92 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.97 | |||||
| 9-Day RSI | 56.83 | |||||
| 14-Day RSI | 54.6 | |||||
| 6-1 Month Momentum % | -21.72 | |||||
| 12-1 Month Momentum % | -16.35 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.94 | |||||
| Quick Ratio | 1.61 | |||||
| Cash Ratio | 1.23 | |||||
| Days Inventory | 90.51 | |||||
| Days Sales Outstanding | 64.54 | |||||
| Days Payable | 52.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.3 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.38 | |||||
| Operating Margin % | 8.94 | |||||
| Net Margin % | 97.93 | |||||
| ROE % | 121.51 | |||||
| ROA % | 34.78 | |||||
| ROIC % | 72.77 | |||||
| ROC (Joel Greenblatt) % | 9.95 | |||||
| ROCE % | 3.91 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 11.91 | |||||
| Forward PE Ratio | 261.27 | |||||
| PE Ratio without NRI | 11.91 | |||||
| Price-to-Owner-Earnings | 12.82 | |||||
| PS Ratio | 11.53 | |||||
| PB Ratio | 7.32 | |||||
| Price-to-Tangible-Book | 6.94 | |||||
| Price-to-Operating-Cash-Flow | 119.82 | |||||
| EV-to-EBIT | 127.21 | |||||
| EV-to-EBITDA | 86.76 | |||||
| EV-to-Revenue | 11.01 | |||||
| EV-to-Forward-Revenue | 8.61 | |||||
| EV-to-FCF | -25.83 | |||||
| Price-to-Median-PS-Value | 1.58 | |||||
| Price-to-Graham-Number | 1.87 | |||||
| Earnings Yield (Greenblatt) % | 0.79 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CDMO
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 125.535 | ||
| EPS (TTM) ($) | 1.77 | ||
| Beta | 1.98 | ||
| Volatility % | 78 | ||
| 14-Day RSI | 54.6 | ||
| 14-Day ATR ($) | 1.053675 | ||
| 20-Day SMA ($) | 17.8275 | ||
| 12-1 Month Momentum % | -16.35 | ||
| 52-Week Range ($) | 11.3 - 34.51 | ||
| Shares Outstanding (Mil) | 62.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avid Bioservices Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avid Bioservices Inc Analysis
Share your researchHeadlines
See More
No news.